Barinthus Biotherapeutics PLC - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Barinthus Biotherapeutics PLC - ADR
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
/ 
Frequently asked questions
To buy Barinthus Biotherapeutics PLC - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Barinthus Biotherapeutics PLC - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Barinthus Biotherapeutics PLC - ADR is BRNS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Barinthus Biotherapeutics PLC - ADR has its primary listing on NASDAQ. You can trade Barinthus Biotherapeutics PLC - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Barinthus Biotherapeutics PLC - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Barinthus Biotherapeutics PLC - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Barinthus Biotherapeutics PLC - ADR.